Share Name Share Symbol Market Type Share ISIN Share Description
The Mission Marketing Group LSE:TMMG London Ordinary Share GB00B11FD453 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 40.50p 40.00p 41.00p 40.50p 40.50p 40.50p 39,514 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Media 144.1 5.9 5.4 7.6 33.78

Mission Marketing Group (TMMG) Latest News

More Mission Marketing Group News
Mission Marketing Group Takeover Rumours

Mission Marketing Group (TMMG) Share Charts

1 Year Mission Marketing Group Chart

1 Year Mission Marketing Group Chart

1 Month Mission Marketing Group Chart

1 Month Mission Marketing Group Chart

Intraday Mission Marketing Group Chart

Intraday Mission Marketing Group Chart

Mission Marketing Group (TMMG) Discussions and Chat

Mission Marketing Group Forums and Chat

Date Time Title Posts
06/12/201711:19The Mission Marketing Group1,094
29/2/200816:46One for 200760

Add a New Thread

Mission Marketing Group (TMMG) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
View all Mission Marketing Group trades in real-time

Mission Marketing Group (TMMG) Top Chat Posts

Mission Marketing Group Daily Update: The Mission Marketing Group is listed in the Media sector of the London Stock Exchange with ticker TMMG. The last closing price for Mission Marketing Group was 40.50p.
The Mission Marketing Group has a 4 week average price of 39.50p and a 12 week average price of 39.50p.
The 1 year high share price is 51.50p while the 1 year low share price is currently 38.50p.
There are currently 83,398,195 shares in issue and the average daily traded volume is 87,645 shares. The market capitalisation of The Mission Marketing Group is £33,776,268.98.
bbluesky: Don't agree about the director selling. Of more interest is the institutional buying that went with it, a big positive. Share price imo at stale bulls point, price driven down on no news and very little volume and an excellent long term buying opportunity.
red_shed2000: Well against my better judgement I have topped up today. I am so over weight here it's untrue but I really don't understand why the share price hasn't moved for 3 years despite ever increasing profits and cash flow. One day they will either fly or be taken over. I just repeat the same phrase here month after month - the market can remain irrational longer than I can remain rational....
thirty fifty twenty: TMMG at 48p – the contract win for DTI is , I think, hugely significant. TMMG share price has been lowly rated for years not for the lack of profit growth, cash generating, debt reduction, or dividend increases! But because of worries re being a people business, the general quality for a small cap plc, the quality of earnings when CASH is regularly used to buy in growth. I think this contract puts these all to bed , and some…. As a multi year contract, across multiple countries, which is of the highest profile (BREXIT for world’s 7th biggest economy!), it means that people will stay with the agency for the experience, it is organic growth rather than an acquisition, it is highly visible and its gives the company huge credibility. So I think it bats away investors previous concerns. What are the financials... well no update from the company yet but it is easy to play around with averages for conferences and get £1m to £2m per year – probably at the lower end of this range. Remember the agency Bray Leino, which has a 20 year growth record, which is c. 40% of TMMG t/o has said it is the most significant thing in their history! So it seems reasonable to assume it is significant. Much more so, I think it wil enable TMMG to pitch and convert to sales much more easily so their will be a significant halo affect. Other aspects… in the last 3 RNS’s TMMG has enthused about all the other agencies and their progress and opportunities – there is little mention of Bray Leino – so this is on top of current expectations. When TMMG announced their ‘growth scheme’ in March the CEO of Bray Leino got the highest level of incentive shares. I thought that was interesting because the salary of all the board members is pretty much the same some take it as salary, others as benefits but , aside from founder David Morgan, they are pretty much banded. – which is intentional to ensure equality amongst these different entrepeneurs. My view is that TMMG felt this contract was a possibility way back at the start of the year and created a ‘growth scheme’ which gave them reward if it was pulled off. At the time the share price hurdle of 75p seems ludicrous compared to the market price of 40p but I think now it gives an indication as to what potential they see in future contracts. And of course we don’t know what else they have yet to announce.. the latest RNS was stuffed full of optimism for future pitches. And the chart…. There is a classic flag break, with volume, out of a growth trend going back to 2010 which predicts a price move to c.80p which was previous resistance. From this break out there is no resistance until that point though I think 50p will be a sticking point for some technical analysis. The catalyst for a major move would be an RNS from the company. Paul Scott owns the shares so I think any positive RNS will be highlighted through him and also ST is likely to update positively. All IMHO, DYOR + BoL TMMG is in my top 5 hldgs
mfhmfh: IMHO solid trading update as usual, share price unlikely to move as usual.
gingerplant: This is simply much too cheap on almost all measures IMO. OK in an absolutely ideal world you'd have a ptbv discount, but given the acquisitions and the nature of the business, they're always stuffed full of intangibles. This is still way cheaper than its peers and whilst the balance sheet isn’t as strong as you'd like, it is improving - and they are VERY cheap on earnings & expect growth this year. Understandably, the Long Term Incentive Plan is unpopular but the target price for the options at 75p is kind of "N/A" AFAIAC. However, a share price of around 65pps (with a corresponding P/E of around 8 and falling) looks much more reasonable IMO; at which the anticipated yield (currently 4.2%) would be 2.77%, so still not unreasonable and only marginally behind the sector average.
red_shed2000: If they get the share price to 75p they are welcome to the shares!!!
red_shed2000: And that article was written when the share price was 47p!!
red_shed2000: Dr Biotech. Agree. Grossly undervalued for years (and I have held for most of those years!) My strategy here has been different to any other share i own in that I have ever ignored the share price going down because I firmly believe it will re-rate at some Tomorrow? Next year? I Don't know but it long as they continue to deliver what they say they will which appears to be the case. GLA.
glasshalfull: Positive results from TMMG with commentary suggesting they are back on the acquisition path. In addition to snippet from oregano (above) Broker finnCap indicate, "The group has produced another strong set of results with operating income up 11% to £61.0m (forecast £60.0m), gross margin up from 43.8% to 46.2% and headline PBT at £6.46m (+17%), 1% ahead of the finnCap forecast of £6.40m. Net debt was higher than expected at £10.9m, an increase of £1.5m over the previous year. This was driven by net cash acquisition expenditure of £2.4m and a £2.0m increase in the working capital requirement, partly as a result of changes in commercial terms with two customers. The group's leverage ratio remained unchanged at 1.3x ...analysis indicates that the group is delivering a growth profile higher than its peers but sits at an EV/EBITDA discount of c25% and a PE discount of 40%. We retain our 60p share price target which implies 36% potential upside and would return the group to the average for its peer group." Forecasts 2016 Turnover £155.5m PBT £7.2m (+10.7%) EPS 6.7p (+13.7%) Div 1.3p (+8.3%) Yield 2.8% Net Debt £8.3m EV £46m 2017 Turnover £167.9m PBT £7.8m (+8.3%) EPS 7.3p (+8.3%) Div 1.4p (+7.7%) Yield 3% Net Debt £5.7m EV £43m Regards, GHF
davebowler: Finncap; The Mission Marketing Group*: Trading update (CORP) The group has issued a trading update for the year to December 2015. The statement confirms that the group has performed well throughout the second half of the financial year and that recent acquisitions are trading well. As a result, final results will be in line with market expectations. The finnCap forecast is for an adjusted PBT of £6.4m, which implies an H2 adjusted PBT of £4.22m. The statement also confirms that net debt will have increased on the last year-end level as a result of the acquisitions, but that the gearing and debt leverage ratios will be broadly unchanged year-on-year and well within internal targets. Following the statement, our 2016 forecast adjusted PBT remains unchanged at £7.4m. At the current 40p share price, the implied 2016 valuation metrics include EV/EBITDA of 4.2x, a PE of 6.0x and a yield of 3.2%. We view this as good value given the forward growth profile and retain our 60p share price target. Final results are expected on 22 March. Analyst: Mark Paddon
Mission Marketing Group share price data is direct from the London Stock Exchange
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:43 V: D:20171211 18:48:09